Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

NCT05066958 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
High Risk Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia, in Relapse
High Risk Acute Lymphoblastic Leukemia
Acute Biphenotypic Leukemia in Relapse
Non-hodgkin Lymphoma
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: boost anti-viral immunity after T-cell depleted HSCT

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology